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angiogenesis (Risau, 1997), to generate larger, branched
vessels. Thus, formation of the yolk sac vasculature
occurs by generation of larger from smaller vessels (Ev-
ans, 1909). This process is coupled to the interconnec-
tion of the embryonic and extraembryonic circulatory
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Recent studies have identified a number of receptor
tyrosine kinases expressed on endothelial cells and their
cognate ligands, which mediate the vasculogenic andSummary
angiogenic development of blood vessels (reviewed in
Folkman and D'Amore, 1996; Hanahan, 1997). FGF-2 isThe vertebrate circulatory system is composed of ar-
an endothelial cell mitogen (Folkman and Klagsbrun,teries and veins. The functional and pathological dif-
1987) and is able in collaboration with vascular endothe-ferences between these vessels have been assumed
lial growth factors (VEGFs) (reviewed in Risau andto reflect physiological differences such as oxygen-
Flamme, 1995) to promote de novo tubule formation byation and blood pressure. Here we show that ephrin-
dispersed endothelial cells in collagen matrices in vitroB2, an Eph family transmembrane ligand, marks arte-
(Goto et al., 1993). VEGF and its receptors, Flk-1 (VEGF-rial but not venous endothelial cells from the onset
R2) and Flt-1 (VEGF-R1), are essential for both vasculo-of angiogenesis. Conversely, Eph-B4, a receptor for
genesis and angiogenesis in vivo (Fong et al., 1995;ephrin-B2, marks veins but not arteries. ephrin-B2
Shalaby et al., 1995). Angiopoietin-1 (Ang-1) and its re-knockout mice display defects in angiogenesis by both
ceptor, TIE2/TEK, are essential for angiogenesis (but notarteries and veins in the capillary networks of the head
vasculogenesis) and proper heart development (Dumontand yolk sac as well as in myocardial trabeculation.
et al., 1994; Sato et al., 1995; Suri et al., 1996). TheseThese results provide evidence that differences be-
ligands are provided to endothelial cells by neighboringtween arteries and veins are in part genetically deter-
mesenchymal cells. Conversely, ligands expressed onmined and suggest that reciprocal signaling between
cardiac endothelial (endocardial) cells, such as neuregu-these two types of vessels is crucial for morphogene-
lin, are also essential for heart formation and activatesis of the capillary beds.
receptors present on neighboring mesenchymal (myo-
cardial) cells (Lee et al., 1995; Meyer and Birchmeier,Introduction
1995). Thus, the process of angiogenesis appears to
involve bidirectional signaling between endothelial cellsArteries and veins are defined by the direction of blood
and the support cells that eventually will ensheath themflow and by anatomical and functional differences. De-
(Folkman and D'Amore, 1996).spite recent intensive study of blood vessel formation
Although mature arteries and veins have obvious dis-
(reviewed in Folkman and D'Amore, 1996; Hanahan,
tinctions in their functional properties and disease sus-
1997; Risau, 1997), surprisingly little attention has been
ceptibilities, it has been assumed that these differences
paid to the question of when and how arteries and veins
arise later in development as a reflection of vascular
acquire their distinct properties. Indeed, these differ-
physiology. Indeed, it has not even been clear that the
ences have been widely assumed to reflect primarily
endothelial cells lining these two types of vessels are
physiological influences such as oxygenation, blood
necessarily different. This is reflected in the fact that
pressure, and shear forces. current models of angiogenesis treat the developing
Blood vessels are comprised of two cellular layers:
endothelial network as an homogeneous population
an inner layer of endothelial cells, which lines the lumen,
(Folkman and D'Amore, 1996; Hanahan, 1997; Risau,
and an outer layer of smooth muscle cells. The first
1997).
tubular structures are formed by the endothelial cells, We now show that arterial and venous endothelial
which subsequently recruit pericytes and smooth mus- cells are molecularly distinct from the earliest stages of
cle cells to ensheath them (Risau and Flamme, 1995). angiogenesis. This distinction is revealed by expression
The de novo formation of blood vessels from a dispersed on arterial cells of a transmembrane ligand, called
population of mesodermallyderived endothelial cell pre- ephrin-B2 (Bennett et al., 1995; Bergemann et al., 1995),
cursors, called angioblasts, is termed vasculogenesis whose cognate receptor Eph-B4 (Andres et al., 1994) is
(Sabin, 1917). Vasculogenesis occurs in several inde- expressed on venous cells. Targeted disruption of the
pendent locations, including the embryo proper, and in ephrin-B2 gene prevents the remodeling of veins from
extraembryonic membranes such as the yolk sac. In the a capillary plexus into properly branched structures.
yolk sac, angioblasts first assemble into a reticulum Moreover, it also disrupts the remodeling of arteries,
of primitive tubules called the primary capillary plexus suggesting that reciprocal interactions between pre-
(Risau, 1997). This network of thin tubules then under- specified arterial and venous endothelial cells areneces-
goes a succession of morphogenetic events involving sary for angiogenesis. Our results suggest that differ-
sprouting, splitting, and remodeling, collectively called ences between arteries and veins are in part genetically
determined and have important implications for thinking
about both the mechanisms of angiogenesis and the³To whom correspondence should be addressed.
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Figure 1. Targeted Disruption of the ephrin-B2 Gene
(A) Exon-1 structure. Filled box represents 59 untranslated region. Hatched box starts at the ATG and includes the signal sequence.
(B) Tail DNA of adult mice was subjected to Southern blot analysis with a 1 kb HindIII±XbaI probe. No 2/2 samples are seen because of the
embyronic lethality of the mutation.
(C) LacZ staining of a 7 somite embryo shows early endothelial signals in heart (arrow) and dorsal aorta (arrowhead) but not in yolk sac (ys).
(D) Growth retardation and enlargment of the heart (arrow) are seen in an E10 mutant embryo. All embryos died by E11.
cellular targets of potential therapeutic agents that pro- E11. No expression of endogenous ephrin-B2 mRNA
was detected by in situ hybridization, indicating that themote or inhibit this process.
mutation is a null (not shown). Somite polarity, hindbrain
segmentation, and the metameric patterning of neuralResults
crest migration (in which ephrin-B2 and related ligands
have previously been implicated [Xu et al., 1995; KrullTargeted Mutagenesis of ephrin-B2 in Mice
Targeted disruption of the ephrin-B2 gene was achieved et al., 1997; Smith et al., 1997; Wang and Anderson,
1997]) appeared grossly normal in homozygous mutantby homologous recombination in embryonic stem cells.
The targeting strategy involved deleting the signal se- embryos (data not shown).
quence and fusing a tau-lacZ indicator gene in frame
with the initiation codon (Figures 1A and 1B). The ex- Reciprocal Expression Pattern of ephrin-B2
and Eph-B4 in Arteries and Veinspression pattern of b-galactosidase in heterozygous
(ephrin-B2tlacZ/1) embryos was indistinguishable from The enlarged heart observed in dying mutant embryos
(Figure 1D, arrow) prompted us to examine the expres-that previously reported for the endogenous gene (Ben-
nett et al., 1995; Bergemann et al., 1995; Wang and sion of ephrin-B2tlacZin the vascular system in detail (see
model diagrams, Figures 2A and 2L). Surprisingly, ex-Anderson, 1997) (Figure 1C). While prominent expres-
sion was detected in the hindbrain and somites, lower pression was consistently observed in arteries but not
veins. In the E9.5 yolk sac, for example, the posteriorlevels were observed in the aorta and heart as early as
E8.25 (Figure 1C, arrow). Expression in the yolk sac was vessels connected to the vitelline artery, but not the
vitelline vein, expressed the gene (Figure 2B). In thefirst detected at E8.5 (Figure 4B). Heterozygous animals
appeared phenotypically normal. In homozygous em- trunk, labeling was detected in the dorsal aorta (Figures
2D and 2E, da), vitelline artery (Figure 2D, va), umbilicalbryos, growth retardation was evident at E10 (Figure
1D) and lethality occurred with 100% penetrance around artery, and its allantoic vascular plexus (Figure 2F, ua,
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avp) but not in the umbilical, anterior, and common detection of a previously unrecognized extensive inter-
cardinal veins (Figure 2D, uv; Figure 2E, acv, ccv). In calation between arteries and veins across the entire
the head, labeling was seen in branches of the internal anterior±posterior extent of the yolk sac (Figures 4F, 4H,
carotid artery (Figure 2L, ica; Figures 2M±2O, arrows) 4L, 4N, and 9A). Double labeling for platelet endothelial
but not in those of the anterior cardinal vein (Figure 2L, cell adhesion molecule (PECAM) and b-galactosidase
acv; Figures 2N and 2O, arrowheads). In situ hybridiza- revealed that the interface between the arteries and
tion with ephrin-B2 cRNA probes confirmed that the veins occurs between microvessel extensions (Figure 4H,
selective expression of tau-lacZ in arteries correctly re- arrowheads) that bridge larger vessels interdigitating en
flected the pattern of expression of the endogenous passant (Figures 4L and 4N, arrowheads; Figure 9B).
gene (Figures 2H and 2J, arrows). Expression of ephrin-
B1 and -B3 was undetectable in endothelial cells of the
trunk and yolk sac at these stages (data not shown). Disrupted Angiogenesis in the Yolk Sac
Examination of the expression of receptors for ephrin- of ephrin-B2tlacZ/ephrin-B2tlacZ Embryos
B2, which include the four Eph-B family genes as well Defects in yolk sac angiogenesis were apparent by E9.0
as Eph-A4/Sek1 (Gale et al., 1996), revealed expression and obvious at E9.5 (Figures 4E, 4G, 4I, and 5). There
of only Eph-B4 in endothelial cells. Surprisingly, this was an apparent block to remodeling at the capillary
expression was observed in veins but not arteries (Fig- plexus stage for both arterial vessels as revealed by
ures 2G, 2I, and 2K, arrowheads), including the vitelline b-galactosidase staining (Figures 4D versus 4E, 4F ver-
vein and its branches in the anterior portion of the yolk sus 4G, 4H versus 4I) and venous vessels in the anterior
sac (Figure 2C, vv, arrowheads), as early as E9.0. region of the sac as revealed by PECAM staining (Fig-
ures 4J, arrowheads, versus 4K). Thus, disruption of the
ephrin-B2 ligand gene caused both a nonautonomous
Vasculogenesis Occurs Normally in ephrin-B2 defect in Eph-B4 receptor-expressing venous cells and
Mutant Embryos an autonomous defect in the arteries themselves.
The formation of the major vessels in the trunk was This defect was accompanied by a failure of intercalat-
unaffected by the lackof ephrin-B2 (Figure 3). The dorsal ing bidirectional growth of arteries and veins (Figure 4L)
aorta, vitelline artery, posterior cardinal, and umbilical across the antero±posterior extent of the yolk sac, so
veins, for example, formed (Figures 3B and 3D), although that an interface between ephrin-B2-expressing and
some dilation and wrinkling of the vessel wall was ob- -nonexpressing zones at the midpoint of the sac was
served. Similarly, the intersomitic vessels originating apparent (Figures 4G, 4I, 4M, and 4O). (However, small
from the dorsal aorta formed at this stage (Figures 3A patches of lacZ expression were occasionally visible
and 3B, arrowheads). Between E8.5 and E9.0, the primi- within the anterior venous plexus [Figures 4M and 4O],
tive endocardium appeared only mildly perturbed in mu- suggesting that some arterial endothelial cells may have
tants (Figure 3B, arrow), while a pronounced disorgani- become incorporated into venous capillaries.) These ob-
zation was apparent at E10 (Figure 6F). Red blood cells servations imply a close relationship between the re-
developed and circulated normally up to E9.5 in both the
modeling of the capillary plexus into larger vessels and
mutant yolk sac and embryo proper (data not shown).
the intercalating growth of these vessels (see Figure
9B). The large b-galactosidase1 vitelline arteries (Figure
4G, arrow) as well as vitelline veins (Figure 4K, arrow-Extensive Intercalation of Yolk Sac
head) present at the point of entry to the yolk sac ofArteries and Veins Revealed
the embryo-derived vasculature (Figure 2A) appearedby ephrin-B2 Expression
unperturbed in the mutant, however. This is consistentIn the yolk sac, the vitelline artery and its capillary net-
with the observation that the mutation does not affectwork occupy the posterior region, and the vitelline vein
formation of the primary trunk vasculature (Figures 3Band its capillaries, the anterior region (Figure 2A). At
and 3D). It also argues that the yolk sac phenotype isE8.5, a stage at which the primary capillary plexus has
due to a disruption of intrinsic angiogenesis and is notformed but remodeling has not yet occurred (Figure 4A),
secondary to a failure of ingrowth of embryo-derivedasymmetric expression of ephrin-B2-tau-lacZ in hetero-
vessels.zygous embryos was evident at the interface between
Histological staining of sectioned yolk sacs revealedthe anterior and posterior regions (Figure 4B). Appar-
an accumulation of elongated support cells in close as-ently homotypic remodeling of b-galactosidase1 arterial
sociation with the endothelial vessels at E10 and E10.5capillaries into larger, branched trunks clearly segre-
(Figures 5B and 5C, arrows). In the mutant yolk sacs,gated from venous vessels was evident between E9.0
these support cells appeared more rounded (Figures 5Eand E9.5 (Figures 4D, 4F, and 4H). At this stage, expres-
and 5F, arrows), suggesting a defect in their differentia-sion of the receptor Eph-B4 was clearly visible on the
tion. Moreover, in contrast to heterozygous yolk sacs,vitelline veins but not arteries (Figure 2C, arrowheads).
where vessels of different diameters began to appearThus, arterial and venous endothelial capillaries are al-
at E9.5 and vessel diameter increased through E10.5ready molecularly distinct following vasculogenesis and
(Figures 5A±5C), capillary diameter appeared relativelyprior to angiogenesis.
uniform and did not increase with age in the mutantsStrikingly, while textbook diagrams (Carlson, 1981) of
(Figures 5D±5F). The mutant capillaries also failed tothe yolk sac capillary plexus depict a nonoverlapping
delaminate from the basal endodermal layer (Figures 5Bboundary between thearterial and venous capillary beds
(Figure 2A), expression of ephrin-B2-tau-lacZ allowed versus 5E, 5C versus 5F).
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Figure 2. Complementary Expression of ephrin-B2 and Its Receptor Eph-B4 in Embryonic Arteries and Veins
(A) A textbook digram of the circulatory system in a young pig embryo (reproduced from Carlson, 1981).
(B and C) Dorsal whole-mount view of E9.5 (25±30 somites) yolk sac showing expression of ephrin-B2 (detected by lacZ staining) in the
vitelline artery (va) (B), or (C) of Eph-B4 (detected by in situ hybridization) in the vitelline vein (vv).
(D) Double staining of lacZ and PECAM-1 in a caudal trunk section. Note expression of ephrin-B2 in the dorsal aorta (da) and vitelline artery
(va) but not in the umbilical vein (uv), which is PECAM labeled.
(E) LacZ staining in a rostral trunk section. ephrin-B2 is not expressed in the anterior cardinal vein (acv) or common cardinal vein (ccv).
(F) LacZ staining identifies ephrin-B2-expressing cells in the umbilical artery (ua) and allantoic vascular plexus (avp).
(G±K) In situ hybridization to adjacent sections in the rostral (H and I) or caudal (G, J, and K) trunk region. Expression of ephrin-B2 (H and J)
or Eph-B4 (G, I, and K) is detected in the dorsal aorta ([H] and [J], da) or umbilical, anterior, and posterior cardinal veins ([G], [I], and [K],
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Figure 3. Normal Vasculogenesis in ephrin-
B2 Mutants
(A and B) PECAM-1 staining of 9 somite em-
bryos. Arrows indicate endocardium, and ar-
rowheads, the intersomitic vessels. da,dorsal
aorta.
(C and D) LacZ and PECAM-1 double staining
of caudal trunk sections of E9.5 embryos.
Note the expression of ephrin-B2-tau-lacZ in
the dorsal aorta (da) and vitelline artery (va),
but not the umbilical and posterior cardinal
veins (uv and pcv, respectively).
Absence of Internal Carotid Arterial Branches ephrin-B2-Dependent Signaling between Endocardial
Cells Is Required for Myocardialand Defective Angiogenesis of Venous
Capillaries in the Head Trabeculae Formation
Examination of ligand and receptor expression in wild-of Mutant Embryos
Similar to the yolk sac phenotype, the capillary bed of type hearts revealed expression in the atrium of both
ephrin-B2 (Figure 7B) and Eph-B4 (Figure 7A). Expres-the head appeared dilated in the mutant (Figures 6N
versus 6M) and apparently arrested at the primary plexus sion of both ligand and receptor was also detected in
the ventricle in the endocardial cells lining the trabecularstage (Figures 6F versus 6B). Staining for b-galactosi-
dase revealed that the anterior-most branches of the extensions of the myocardium (Figures 7C, arrows, and
7E). Double labeling experiments suggested that theinternal carotid artery failed to develop in the mutant
(Figures 6C versus 6D, 6G versus 6H, 6I versus 6J, 6K ligand and receptor are expressed by distinct but par-
tially overlapping cell populations, although the resolu-versus 6L, arrows). Unlike the case in the yolk sac, there-
fore, the malformed capillary beds must be entirely of tion of the method does not permit us to distinguish
whether this overlap reflects coexpression by the samevenous origin. However, the anterior branches of the
anterior cardinal vein formed, although they wereslightly cells or a close association of different cells (data not
shown). In any case, expression of ephrin-B2 and Eph-dilated (Figure 6E versus 6F, 6K versus 6L, arrowheads).
Taken together, these data indicate that, in the head, B4 does not define complementary ventricular and atrial
compartments of the heart, although expression of thevenous angiogenesis is blocked if the normal interaction
with arterial capillaries is prevented. The angiogenic de- ligand appears much higher in the atrium than in the
ventricle (Figure 7B).fects observed in the head and yolk sac are unlikely to
be secondary consequences of heart defects (see below), Heart defects commenced at E9.5 and were apparent
in mutant embryos at E10 both morphologically (Figuresince they are observed starting at E9.0, and the embry-
onic blood circulation appears normal until E9.5. 1D) and by whole-mount PECAM staining (Figures 7E
uv, acv, and pcv, respectively).
(L) A classical diagram showing the arteries (internal, darker) and veins (superficial, lighter) in the 25 somite stage chick head (reproduced
from Evans, 1909); acv, anterior cardinal vein; ica, internal carotid artery.
(M and N) Vessels of the E9.5 mouse head. Darker-colored branches of the internal carotid artery can be singled out in PECAM-1 stained
vessels ([N], arrow), which is the only vessel labeled by lacZ staining ([M], arrow).
(O) A cross section of a lacZ- and PECAM-1-double-stained head. Arrows indicate branches of the internal carotid artery, arrowheads indicate
branches of the anterior cardinal vein.
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Figure 4. The ephrin-B2 Mutation Blocks Angiogenesis in the Yolk Sac
(A±C) PECAM-1 (A) and lacZ (B and C) stained E8.5 yolk sacs. The sacs are oriented with the posterior (arterial) and anterior (venous) regions
to the left and right, respectively (see also Figure 2A).
(D and E) LacZ-stained E9.0 yolk sacs.
(F and G) LacZ- stained E9.5 yolk sacs. Arrows indicate vitelline arteries (va).
(H and I) Higher magnifications of yolk sacs shown in (F) and (G). Arrowheads in (H) indicate arterial capillaries.
(J and K) PECAM-1 reveals vessels draining back to the vitelline vein (vv). Arrowheads show the conjugation of the veins. Note that the arterial
and venous networks in the mutant appear arrested at the capillary plexus stage (cf., [I], [K], and [A]).
(L and M) LacZ and PECAM-1 double labeling reveals the boundaries between arterial (blue) and venous (brown) capillaries. Note the
bidirectional (arrows) intercalation of the arteries (a) and veins (v) in the heterozygote (L), which is lacking in the mutant (M).
(N and O) Higher magnifications of the boundaries shown in (L) and (M). Arrowheads in (N) indicate the endings of arterial capillaries.
and 7F, arrows). Sections revealed an absence of myo- and Birchmeier, 1995). Paradoxically, however, in this
case the Eph-B4 receptor is expressed not on myocar-cardial trabecular extensions, although strands of ephrin-
B2-expressing endocardial cells were still visible (Figure dial cells, as is the case for the neuregulin-1 receptors
erbB2 and erbB4 (Gassmann et al., 1995; Lee et al.,7G). Thus, mutation of the ligand-encoding gene caused
a nonautonomous defect in myocardial cells similar to 1995), but rather onendocardial cells. We failed to detect
expression of any of the other receptors for ephrin Bthe effect of a mutation in the neuregulin-1 gene (Meyer
Essential Role of ephrin-B2 in Angiogenesis
747
Figure 5. Defective Interactions between Endothelial and Supporting Cells in the Mutant Yolk Sacs
LacZ-stained heterozygous (A±C) and homozygous mutant (D±F) yolk sacs were sectioned and mesenchymal cells surrounding the blood
vessels revealed by hematoxylin staining. Single arrows (B±F) indicate elongating mesenchymal cells or pericytes surrounding the endothelial
cells at E10 (B and E) and E10.5 (C and F). Note the more rounded morphology of these cells in the mutant ([E] and [F], single arrows). Asterisks
(B and C) indicate lacZ-negative veins. Note also the failure of vessels to delaminate from the underlying endoderm (double arrows) in the
mutant (cf., [C] versus [F]). Arrowhead in (B) indicates ephrin-B21 endothelial cells that may be migrating into an arterial vessel. At E10.5 (F),
arteries appear dilated, as if fusion of vessels occurred without encapsulation by support cells (C).
family ligands (Eph-B1, -B2, -B3, and -A4) in this tissue begun to emerge (Risau and Flamme, 1995; Folkman
and D'Amore, 1996; Risau, 1997). While explosive prog-(data not shown). This suggests that in the heart, ligand-
receptor interactions among endothelial cells may in ress has been made in identifying growth factors and
receptors that control vasculogenesis and angiogenesisturn affect interactions with myocardial cells.
(Hanahan, 1997), none of these advances have illumi-
nated the problem of vessel identity. Indeed, in the ab-ephrin-B2 Is Required for Vascularization
of the Neural Tube sence of markers to distinguish vessel types, both clas-
sical (Evans, 1909; Carlson, 1981) and modern (FolkmanIn ephrin-B2tlacZ/ephrin-B2tlacZ embryos, capillary ingrowth
into the neural tube failed to occur (Figures 8A versus and D'Amore, 1996; Risau, 1997) views of blood vessel
formation have treated developing capillary networks8B). Instead, ephrin-B2-expressing endothelial cells re-
mained associated with the exterior surface of thedevel- as a uniform structure. The expression pattern of ephrin-
B2 and its receptor Eph-B4 establishes a new conceptoping spinal cord (Figure 8B, arrow). Comparison of
b-galactosidase to pan-endothelial PECAM and Eph-B4 in angiogenesis: arterial and venous endothelial cells
have distinct identities from the earliest stages of bloodexpression (data not shown) provided no evidence of a
separate, venous capillary network expressing Eph-B4 vessel formation. The essential role of ephrin-B2 in angi-
ogenesis, moreover, suggests that reciprocal interac-in the CNS at this early stage (E9±E10). Rather, expres-
sion of a different ephrin-B2 receptor, Eph-B2, was seen tions between arteries and veins are intrinsic to the ves-
sel remodeling process.in the neural tube (Figure 8C), as previously reported
(Henkemeyer et al., 1994), where no gross morphologi-
cal or patterning defects were detectable (data not Vessel Identity Is Established at the Earliest
Stages of Angiogenesisshown). In this case, therefore, the mutation does not
appear to cause a nonautonomous phenotype in recep- The extent to which an artery-specific molecular marker
changes our view of the basic ontogenetic anatomy oftor-expressing cells, rather, only an autonomous effect
on ligand-expressing cells. the embryonic vasculature is illustrated by the case of
the yolk sac. Textbook diagrams (Carlson, 1981; Gilbert,
1997) of the yolk sac capillary bed indicate a nonoverlap-Discussion
ping apposition of arterial and venous capillaries at the
midline of the structure (Figure 2A). Strikingly, however,The study of blood vessel formation was primarily an
anatomical and descriptive subject since the beginning lacZ staining of ephrin-B2tlacZ/1 embryos revealed that
this inferred structure is completely wrong. By distin-of this century (Evans, 1909). Only in the last few years
have the molecular mechanisms underlying this process guishing small arteries from veins, we were able to
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Figure 6. Defective Angiogenesis in the Head
(A and B) PECAM-1-stained E8.5 heads. (C±F) LacZ- or PECAM-1-stained E9.0 heads. (G and H) LacZ-stained E9.5 heads. (I and J) Sections
of lacZ-stained heads shown in (G) and (H). Arrows (I) indicate branches of the internal carotid artery. Side (K and L) or dorsal (M and N) views
of PECAM-1-stained E9.5 heads. Darker-colored branches of the internal carotid artery can be singled out in PECAM-1-stained vessels of
heterozygous embryos (arrows in [E], [K], and [M]). Arrowheads indicate branches of the anterior cardinal veins in (E), (F), (K), and (L). Note
again the apparent arrest of angiogenesis at the capillary plexus stage in the mutant (B, F, L, and N).
visualize an extensive intercalation between the two angiogenic or antiangiogenic drugs have artery-selec-
tive effects in vivo.types of vessels during yolk sac morphogenesis (Figures
4H, 4L, and 9A). Such interdigitation may be essential Most or all embryonic arteries express ephrin-B2 and
veins, Eph-B4, at the stages we examined. Furthermore,to distribute interactions between arteries and veins
throughout the developing capillary bed (Figure 9B). The we were unable to detect expression on yolk sac or
trunk endothelial cells of ephrins-B1 and -B3 as well asavailability of ephrin-B2tlacZ mice may similarly reveal un-
discovered features of the morphogenesis of arterial of their receptors Eph-B1, -3, and -A4. However, this
should not be taken to imply that these are the onlyand venous networks during angiogenesis in the adult.
It may also provide an opportunity to examine whether ephrins and Eph receptors expressed by arterial and
Essential Role of ephrin-B2 in Angiogenesis
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Figure 7. Receptor-Ligand Expression in the Heart and Defects in the Mutants at E10
(A and B) In situ hybridization of Eph-B4 (A) and lacZ staining of ephrin-B2 (B) in the atria and ventricles.
(C and D) Higher magnifications of receptor or ligand expression in the ventricles.
(E and F) Whole-mount views of PECAM-1-stained heterozygous (E) and homozygous mutant (F) hearts. Arrows indicate the ventricles.
(G) Section through a lacZ-stained mutant heart.
venous endothelial cells in later development or adult- not exhibit any detectable phenotype (Chen et al., 1996).
We have not yet explored the expression of Eph-A-classhood. For example, human renal microvascular endo-
thelial cells (HRMEC) (Martin et al., 1997) have recently receptors and their ephrin-A-class ligands on embryonic
arteries and veins in vivo. However, the phenotype ofbeen shown to express Eph-B1 and Eph-B2 as well as
ephrin-B1 and ephrin-B2 (Stein et al., 1998). However, the ephrin-B2 mutant in the yolk sac, head, and heart
suggests that there is not substantial functional redun-the finding that both Eph-B-class receptors and ephrin-
B-class ligands are expressed on this same cell popula- dancy of ephrin ligands in these regions at the embry-
onic stages we have examined. Nevertheless, othertion is not in contradiction to our observations, since
HRMEC are not of defined arterial or venous origin (and ephrins and their receptors could be expressed in differ-
ent vessels or vascular beds at different stages of devel-may in fact represent a mixture of the two) or may have
lost their vessel identity in vitro. opment or in the adult (Stein et al., 1998).
Eph-A-class receptors and their ligands have also
been implicated in angiogenesis. Human umbilical vein ephrin-B2-Mediated Interactions Are Essential
for Angiogenesis of Arteries and Veinsendothelial cells (HUVECs) express Eph-A2, and TNF-
a-induced angiogenesis is mediated by ephrin-A1 in The pattern of phenotypic defects caused by the ephrin-
B2 mutation, taken together with the complementaryvivo (Pandey et al., 1995). Eph-A2 mutants, however, do
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Figure 8. Neurovascular Defects in the Mutants
(A and B) Transverse sections of lacZ-stained E9.5 heterozygous (A) and homozygous mutant (B) trunk neural tube.
(C) In situ hybridization of Eph-B2 receptor in E9.5 heterozygous trunk neural tube.
expression of this ligand and its receptor by arteries and the question of whether this receptor is required for
signaling from veins to arteries and should provide aveins, respectively, suggests that reciprocal signaling
useful marker of venous vessels as well.between these two classes of vessels is essential for re-
The biochemical functions promoted by ephrin/eph-modeling the capillary network. For example, in the head
mediated signaling, and their role in the angiogenic re-the ephrin-B2 mutation not only blocks branching of the
modeling process, remain to be explored. One hint,how-internal carotid artery, but it also prevents remodeling
ever, is provided by recent studies which indicate thatof the capillary bed of the anterior cardinal vein. This
the ephrin-B receptor Eph-B2/Nuk interactsdirectly withimplies that ephrin-B2 provides a signal from arteries
regulators of GTPases, including ras-GAP, and indirectlyto veins that is essential for remodeling of the latter. A
with regulators of small GTPases via Nck (Holland et al.,similar defect in venous capillary remodeling is seen in
1997). These GTPases have in turn been implicated inthe yolk sac; here, however, remodeling of the intrinsic
membrane±actin cytoskeletal rearrangements that un-arterial capillary network is blocked as well. This sug-
derly both axon guidance (Garrity et al., 1996) and thegests that a reciprocal signal from veins to arteries is
formation of membrane specializations such as focalalso necessary for arterial angiogenesis.
contacts between cells (reviewed in Hall, 1998; HollandSince ephrin-B2 and related transmembrane ephrin-
et al., 1998). These cell±cell junctions are important inB-type ligands have been shown capable of intracellular
capillary bed formation and are mediated, at least insignaling (Holland et al., 1996; Bruckner et al., 1997),
part, by endothelial cell-specific adhesion moleculesthe simplest explanation for this putative reciprocal arte-
such as vascular endothelial cadherin (VE-CAD) (Na-rial±venous signaling would be that ephrin-B2 acts both
varro et al., 1998). It will be interesting to determineas a ligand and as a receptor for Eph-B family trans-
whether ephrin-B2-mediated signaling is required formembrane kinases expressed on veins. In this way, the
the establishment of such junctions in vivo.same receptor/ligand pair would mediate bidirectional
The cellular consequences of ephrin signaling in angi-signaling between arteries and veins. We were unable
ogenesis have yet to be determined. In the nervous
to detect expression on yolk sac endodermal cells of
system, ephrins have been implicated as repulsive guid-
any other ephrin-B2-interacting receptors at E9.5±10.0.
ance cues for axon growth and neural crest cell migra-However, we cannot exclude the possibility that other
tion (reviewed in Holland et al., 1998). By analogy, mutu-
Eph-B class receptors are expressed below the detec-
ally repulsive interactions between arteries and veins
tion limit of our in situ hybridization technique on mesen-
mediated by ephrins could be important in establishing
chymal or endodermal cells and also signal to arterial the proper balance of these two vessel types in capillary
cells via ephrin-B2. beds. On the other hand, ephrin-A1 has been shown to
It is formally possible that the arterial defects in the promote angiogenesis in vivo as well as endothelial cell
mutant reflect an autonomous function for ephrin-B2 chemotaxis (Pandey et al., 1995), and very recently
and that the venous defects are a secondary conse- ephrin-B1 has been shown to promote capillary-like as-
quence of altered or absent blood flow in the defective sembly of renal endothelial cells in vitro (Stein et al.,
arteries. We feel this is unlikely, not only because veins 1998). Thus, these latter data suggest that ephrin signal-
express the Eph-B4 receptor for ephrin-B2, but also ing may mediate stimulatory rather than inhibitory influ-
because ephrin-B2-dependent remodeling events begin ences on endothelial cells. Purification of ephrin-B21
at E8.5, before the heart starts to beat regularly (E9.0; arterial and Eph-B41 venous endothelial cells should
Kaufman, 1992). Conversely, the arterial defects in the permit in vitro studies that will address this issue.
mutant are unlikely to simply reflect changes in venous
blood flow, because a similar angiogenic defect is ob- Potential Interactions between ephrin
served in the neural tube, where vascularization requires and Angiopoietin Signaling
an interaction between ephrin-B21 endothelial cells and The angiogenic phenotype of the ephrin-B2 mutation in
Eph-B2-expressing neuroepithelial cells (Figure 8C). the head and yolk sac appears similar to that of muta-
tions in the receptor TIE2 (Sato et al., 1995) and its ligandTargeted disruption of Eph-B4 should directly address
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mesenchymal cell differentiation, as does defective sig-
naling between the endothelial cells and the mesenchy-
mal cells themselves? One attractive possibility is that
ephrin-B2-Eph-B4-mediated interendothelial signaling
is required for either production of or responsiveness to
Ang-1. Alternatively, Ang-1 signalingcould benecessary
for the expression or function of the ephrin-B2-Eph-B4
ligand-receptor pair. Genetic epistasis experiments may
help to distinguish between these possibilities. What-
ever the case, what was previously conceived of as a
two-way conversation between endothelial and mes-
enchymal cells may actually be a three-way conversa-
tion between mesenchymal cells, arteries, and veins
(Figure 9C).
The Implications of Molecular Distinctions
between Arteries and Veins
The finding that arterial and venous endothelial cells
are genetically distinct raises new questions relevant to
both basic and clinical research into vasculogenesis and
angiogenesis. How are arterial and venous angioblasts
initially specified? Do arterial and venous angioblasts
display homotypic vasculogenic or angiogenic proper-
ties? Do activators and inhibitors of angiogenesis act
equivalently on each type of endothelial cell, or do they
exhibit arterial or venous specificity? The roles of eph-
rins and their receptors in tumor angiogenesis (Hanahan
and Folkman, 1996) or myocardial neovascularization
(Schumacher et al., 1998) also remain to be explored.
Finally, our results indicate that the physiological and
pathological distinctions between mature arteries and
veins are not due simply to differences in their anatomy,
oxygenation, or blood pressure, but rather are geneti-
Figure 9. Summary of the Endothelial Expression of ephrin-B2 and cally determined. This implies that arteries and veins
Eph-B4, and Deduced Mechanistic Models are likely todiffer in their expression of many other genes
(A) Distinction of arteries and veins by the expression of ephrin-B2 as well. The identification of such genes may not only
and Eph-B4, and their coexpression in the heart in early mouse inform our understanding of vascular physiology, but
embryos. Note the intercalation of arteries and veins in the yolk sac.
may also shed light on the different disease suceptibili-Modified from Carlson (1981).
ties of these two types of vessels. In turn, this may lead(B) Ontogeny of arterial±venous intercalation during yolk sac morph-
orgenesis. Vascular stage nomenclature is according to Risau to novel artery- or vein-specific angiogenic or antiangio-
(1997). The ephrin-B2 mutation arrests yolk sac angiogenesis at the genic therapies.
primary plexus stage (see Figure 4).
(C) Revised model of cell±cell interactions in angiogenesis, modified
Experimental Proceduresfrom Folkman and D'Amore (1996).
Abbreviations: ea, arterial endothelial cell; ev, venous endothelial cell; Targeted Disruption of the ephrin-B2 Gene
m, mesenchymal cell.
A 200 bp probe starting from the ATG of the mouse ephrin-B2 gene
(Bennett et al., 1995) was used to screen a 129SVJ genomic library
(Stratagene). Analysis of several overlapping clones revealed thatAngiopoietin-1 (Suri et al., 1996). Those data have been
the first exon, including the signal sequence, ends at 131 bp after
interpreted to suggest that mesenchymal cells signal the ATG. Further phage analysis and library screens revealed that the
via Ang-1 to tie-2-expressing endothelial cells, which in rest of the ephrin-B2 gene was located at least 7 kb downstream
from the first exon. To constructa targeting vector, a 3 kb Xba1±NcoIturn secrete a reciprocal signal (possibly PDGF or HB-
fragment whose 39 end terminated at the ATG was used as the 59EGF) that recruits the mesenchymal cells to differentiate
arm. A 5.3 kb tau-lacZ coding sequence (Mombaerts et al., 1996)to smooth muscle cells and pericytes that form the ves-
was fused in frame after the ATG. The PGKneo gene (Ma et al.,sel wall (Folkman and D'Amore, 1996). Sections of the
1998) was used to replace a 2.8 kb intronic sequence 39 to the first
yolk sac in ephrin-B2 mutants reveal apparent defects exon. Finally, a 3.2 kb downstream EcoRI±EcoRI fragment was used
in themorphological differentiation of vessel-associated as the 39 arm. Normal (6 kb) and targeted (9 kb) loci are distinguished
by HindIII digestion when probed with a 1 kb HindIII±XbaI genomicsupport cells (Figures 5E and 5F). A more dramatic phe-
fragment (Figure 1A). Electroporation, selection, and blastocyst-notype is seen in the heart where (as in the tie-2 and
injection of AB-1 ES cells were performed essentially as describedang-1 mutants) formation of the myocardial trabeculae
(Ma et al., 1998), with the exception that FIAU-selection was omitted.is disrupted, although here again both ligand and recep-
ES cell targeting efficiency via G418 selectionwas 1 out of 18 clones.
tor are expressed by endothelial cells. Germline transmission of the targeted ephrin-B2 locus in heterozy-
How could defective reciprocal signaling between en- gous males was confirmed by Southern blotting. Subsequent geno-
typing was done by genomic PCR. Primers for Neo are 59-AAGATGGdothelial cells produce an apparently similar defect in
Cell
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ATTGCACGCAGGTTCTC-39 (59) and 59-CCTGATGCTCTTCGTCCA tek, reveal a critical role in vasculogenesis of the embryo. Genes.
Dev. 8, 1897±1909.GATCAT-39 (39). Primers for the replaced intronic fragment are
59-AGGACGGAGGACGTTGCCACTAAC-39 (59) and 59-ACCACCAGTT Evans, H.M. (1909). On the development of the aortae, cardinal and
CCGACGCGAAGGGA-39 (39). umbilical veins, and the other blood vessels of vertebrate embryos
from capillaries. Anat. Rec. 3, 498±518.
LacZ, PECAM-1, and Histological Staining Folkman, J., and Klagsbrun, M. (1987). Angiogenic factors. Science
Embryos and yolk sacs were removed between E7.5 and E10.0, 235, 442±447.
fixed in cold 4% paraformaldehyde/PBS for 10 min, rinsed twice
Folkman, J., and D'Amore, P.A. (1996). Blood vessel formation: what
with PBS, and stained for 1 hr to overnight at 378C in X-Gal buffer
is its molecular basis? Cell 87, 1153±1155.
(1.3 mg/ml potassium ferrocyanide, 1 mg/ml potassium ferricyanide,
Fong, G.-H., Rossant, J., Gertsenstein, M., and Breitman, M.L.0.2% Triton X-100, 1 mM MgCl2, and 1 mg/ml X-Gal in PBS [pH
(1995). Role of the Flt-1 receptor tyrosine kinase in regulating the7.2]). LacZ-stained embryos were post-fixed and photographed or
assembly of vascular endothelium. Nature 376, 66±70.sectioned on a cryostat after embedding in 15% sucrose and 7.5%
Gale, N.W., Holland, S.J., Valenzuela, D.M., Flenniken, A., Pan, L.,gelatin in PBS. Procedures for whole-mount or section staining with
Ryan, T.E., Henkemeyer, M., Strebhard, K., Hirai, H., Wilkinson, D.G.,anti-PECAM-1 antibody (clone MEC 13.3, Pharmingen) were done
et al. (1996). Eph receptors and ligands comprise two major specific-essentially as described (Fong et al., 1995; Ma et al., 1998). HRP-
ity subclasses, and are reciprocally compartmentalized during em-conjugated secondary antibodies (Jackson) were used for all
bryogenesis. Neuron 17, 9±19.PECAM-1 stainings except for Figure 4, where alkaline phosphatase
was the enzyme of choice. LacZ-stained yolk sacs were sectioned Garrity, P.A., Rao, Y., Salecker, I., McGlade, J., Pawson, T., and
in gelatin and then subjected to hematoxylin counterstaining by Zipursky, S.L. (1996). Drosophila photoreceptor axon guidance and
standard procedures. targeting requires the dreadlocks SH2/SH3 adapter protein. Cell 85,
639±650.
In Situ Hybridization Gassmann, M., Casagranda, F., Orioli, D., Simon, H., Lai, C., Klein,
In situ hybridization on frozen sections was performed as previously R., and Lemke, G. (1995). Aberrant neural and cardiac development
described (Birren et al., 1993). Whole-mount in situ hybridization in mice lacking the erbB4 neuregulin receptor. Nature 378, 390±394.
followed a protocol by Wilkinson (Wilkinson, 1992). pBluescript vec- Gilbert, S.F. (1997). Developmental Biology, Fifth Ed., (transl.) (Sun-
tors (Stratagene) containing cDNAs for Eph-B2/Nuk and Eph-B4/ derland, MA: Sinauer Associates, Inc.).
Myk-1 were generated as described (Wang and Anderson, 1997).
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